首页 | 本学科首页   官方微博 | 高级检索  
     


Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind,placebo-controlled,non-inferiority,randomised phase 3 trials
Authors:Dale N Gerding  Oliver A Cornely  Simon Grill  Hilke Kracker  Anne Claire Marrast  Carl Erik Nord  George H Talbot  Martha Buitrago  Iulian Gheorghe Diaconescu  Claudia Murta de Oliveira  Liliana Preotescu  John Pullman  Thomas J Louie  Mark H Wilcox
Affiliation:1. Edward Hines Jr Veterans Administration Hospital, Hines, IL, USA;2. Department of Internal Medicine, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Clinical Trials Centre Cologne, University of Cologne, Cologne, Germany;3. Actelion Pharmaceuticals, Allschwil, Switzerland;4. Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden;5. Talbot Advisors, Anna Maria, FL, USA;6. Snake River Research, Idaho Falls, ID, USA;7. Victor Babes Clinical Hospital of Infectious Diseases and Pneumophysiology, Craiova, Romania;8. Santa Casa de Belo Horizonte, Serviço de Controle de Infecção Hospitalar, Belo Horizonte, Brazil;9. Matei Bals National Institute of Infectious Diseases, Bucharest, Romania;10. Mercury Street Medical Group, Butte, MT, USA;11. Foothills Medical Center, Alberta Health Services & University of Calgary, Cumming School of Medicine, Calgary, AB, Canada;12. Microbiology, Old Medical School, Leeds General Infirmary, Leeds, UK
Abstract:
Keywords:Correspondence to: Dr Dale N Gerding   Edward Hines Jr Veterans Administration Hospital   Hines   IL 60141   USA
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号